Lv5
1025 积分 2024-05-14 加入
Primary and acquired resistance to PD-1/PD-L1 blockade in cancer treatment
15天前
已完结
Programmed Death-Ligand 1 Tumor Proportion Score and Overall Survival From First-Line Pembrolizumab in Patients With Nonsquamous Versus Squamous NSCLC
2个月前
已完结
Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma
2个月前
已完结
Global variations in lung cancer incidence by histological subtype in 2020: a population-based study
2个月前
已完结
AGR, LMR and SIRI are the optimal combinations for risk stratification in advanced patients with non-small cell lung cancer following immune checkpoint blockers
3个月前
已完结
Prospective validation study of nutritional and immunological predictors in immune checkpoint inhibitor efficacy for non‐small cell lung cancer
3个月前
已完结
AGR, LMR and SIRI are the optimal combinations for risk stratification in advanced patients with non-small cell lung cancer following immune checkpoint blockers
4个月前
已完结
Exploration of Fully‐Automated Body Composition Analysis Using Routine CT‐Staging of Lung Cancer Patients for Survival Prognosis
4个月前
已完结
Body Composition in Advanced Non-Small Cell Lung Cancer Treated With Immunotherapy
4个月前
已完结
Explanation of the obesity paradox of immunotherapy in cancer patients using CT-derived adipose composition parameters: A systematic review and meta-analysis
6个月前
已完结
皖公网安备34019202002308
